RECENT NEWS

HSIB’s latest report reinforces that specific guidance, detailed multi-agency information and improved access to specialist safeguarding support is crucial for ED clinicians that suspect a baby or young child’s injuries are non-accidental.

​A new study involving 437,704 participants suggests that those experiencing hearing loss and not using hearing aids may have a higher risk of developing dementia than people without hearing loss or those who use hearing aids.

Three in every four people survive their cancer the first year after being diagnosed, with rates of survival for some cancers even higher, according to NHS England's latest figures.

Cardiff based Eakin Healthcare Surgical, part of the Eakin Healthcare Group, has unveiled a new brand identity as part of its gradual transition to the Eakin Healthcare branding.

Harrogate-based charity, AfPP, are pleased to announce the launch of an investigative initiative into the moving and handling training that is provided within the perioperative environment. AfPP are committed to improving patient care by enhancing the skills and knowledge of healthcare professionals who work around the operating theatre.

A recent study conducted by the Royal College of Physicians (RCP) has found that most clinicians feel they haven’t received enough training on health inequalities and would like more as part of their medical education.

For patients with high blood pressure in their pulmonary arteries caused by chronic blood clots, complications after a minimally invasive balloon angioplasty have decreased substantially over the last decade, a Michigan Medicine-led study finds.

NHS England and Health Education England have legally merged to create a new, single organisation to lead the NHS in England.

Women are more likely than men to develop Alzheimer’s disease (AD), with women making up two-thirds of the population living with AD. A new study, led by Mass General Brigham researchers, sheds light on the relationship between the risk of Alzheimer’s disease and age of menopause and use of hormone replacement therapy (HRT).

Wearable devices such as smart watches could be used to detect a higher risk of developing heart failure and irregular heart rhythms in later life, suggests a new study led by UCL researchers.

A cohort study of more than 2,500 people found that the use of monoclonal antibodies to treat COVID-19 within two days of receiving a positive COVID-19 test reduced their risk of hospitalisation or death by 39 percent compared to persons who were eligible for monoclonal antibody treatment but did not receive it.

There were major ethnic, religious, and social differences in the risk of testing positive for SARS-CoV-2, the virus responsible for COVID-19 infection, between the second and third waves of the pandemic in England, finds research published in the open access journal, BMJ Medicine.

Scientists have demonstrated for the first time that, globally, the association between antibiotic consumption and antimicrobial resistance (AMR) between human and animals goes both ways.

The countdown has begun for the Central Sterilising Club's Annual Scientific Meeting, which takes place next week at the Crowne Plaza, Newcastle Upon Tyne, 3-4 April 2023.

More than 75% of patients facing amputation from the most severe form of peripheral artery disease were able to keep their limb after an innovative treatment as part of a multicentre study published in the New England Journal of Medicine.

Researchers at the University of Massachusetts' New England Center of Excellence in Vector-Borne Diseases (NEWVEC) have completed research that offers a promising lead in the fight against Lyme disease.

The latest analysis of the NatCen British Social Attitudes survey by the Nuffield Trust and the King's Fund finds that satisfaction with the NHS dropped to new lows in 2022.

Over 20 leading UK HealthTech innovators have headed to Texas this week to boost export opportunities as part of the first major trade visit organised by the Association of British HealthTech Industries (ABHI) for its new class of ABHI US Accelerator companies.

Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared to usual care. The beneficial effects of early rhythm control were shown by the pan-European EAST – AFNET 4 trial and confirmed by other large health studies. However, what is the price of the new treatment strategy?

The MPS Foundation - a global not-for-profit research initiative that aims to shape the future of patient safety – has launched its second grant programme.